Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

 

Publications

  • Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
    Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
    Journal: Annals of the Rheumatic Diseases
    Year: 2025

  • Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
    Journal: Modern Rheumatology
    Year: 2025

  • Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
    Journal: RMD Open
    Year: 2025

  • Article: Time trends of variability in disease activity in systemic lupus erythematosus
    Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
    Journal: Lupus Science and Medicine
    Year: 2025

  • Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
    Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
    Journal: Rheumatology and Therapy
    Year: 2025

 

Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications

  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Linmang Qin | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Linmang Qin | Medicine and Dentistry | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Lin Mang Qin pursued a Bachelor's degree in Clinical Medicine from Jiujiang University, where he ranked in the top 1% based on comprehensive assessments. He continued his academic journey by completing a Master's degree in Clinical Medicine at South China University of Technology, earning first-class academic scholarships each year during his master's studies.

Professional Endeavors

Currently serving as a Scientific Research Assistant at Guangdong Provincial People’s Hospital since August 2022, Prof. Qin has been deeply involved in theoretical studies, clinical work, and scientific research over the past four years. His responsibilities include conducting basic scientific research at the hospital's public experimental platform and supervising scientific research experiments.

Contributions and Research Focus

Prof. Qin has contributed significantly to the field of clinical medicine, particularly in areas related to autoimmune diseases and gene expression analysis. His research focuses on topics such as fibroblast mesenchymal transition in systemic sclerosis-associated interstitial lung disease (SSc-ILD) and gene expression profiling in polymyositis.

Accolades and Recognition

Prof. Qin's research has garnered international recognition, with publications in prestigious journals such as "iScience" and "Heliyon." Notably, his work has been nominated for the Best Researcher Award, and his methods have been praised by journals for their potential impact on the scientific community.

Impact and Influence

Prof. Qin's research has contributed to advancing our understanding of autoimmune diseases and gene expression regulation, potentially paving the way for novel therapeutic interventions. His involvement in national natural science projects and collaborations with esteemed institutions reflect his impactful contributions to the scientific community.

Legacy and Future Contributions

As the team leader of the public experimental platform at Guangdong Provincial People's Hospital, Prof. Qin continues to mentor and train aspiring researchers while actively engaging in cutting-edge scientific research. His proficiency in various scientific research techniques and dedication to advancing medical knowledge position him as a leader in the field, with a promising future marked by continued innovation and discovery.

Notable Publications

CD4+LAG3+T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3 2023

Screening and validation of differentially expressed genes in polymyositis 2024